A report from GHTC and Policy Cures Research examines how US federal funding for global health R&D is delivering impact both abroad and at home.

Search the GHTC website

News

News
PATH/Aaron Joel Santo
April 30, 2018

GHTC analysis on benefits to states of global health R&D featured in World Pharma News

World Pharma News featured the release of GHTC's new analysis highlighting the economic and health benefits of global health R&D across states.

Read time: 5 minutes / External link
PATH/Doune Porter
April 30, 2018

GHTC state analysis featured in YubaNet

GHTC's analysis on the economic benefits of US investments in global health R&D was featured in YubaNet, a online publication covering California news.

Read time: 5 minutes / External link
PATH/Patrick McKern
April 30, 2018

ScienMag covers GHTC state analysis

ScienMag featured GHTC's state analysis and online tool exploring the economic and health benefits of global health R&D.

Read time: 5 minutes / External link
PATH/Will Marlow
April 29, 2018

GHTC submits FY19 testimony to House appropriators

GHTC submitted written testimony to key House appropriations subcommittees urging them to sustain and protect global health R&D funding in the fiscal year 2019 (FY19) budget.

Read time: 16 minutes
GHTC sent letters to the House appropriations subcommittees with jurisdiction over the US Agency for International Development and Department of State and the Department of Health and Human Services and its subagencies urging these subcommittees to sustain and protect global health R&D funding in the fiscal year 2019 (FY19) budget.